Bayer Aktiengesellschaft
BAYRY
Rank in Stocks
#397
Bayer Aktiengesellschaft operates as a life science company in Europe, the... Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and womenโs health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Share Price
$15.94
Last synced: 2026-11-11
Market Cap
$62.27B
Change (1 day)
-0.25%
Change (1 year)
85.35%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Bayer Aktiengesellschaft (BAYRY)
Category
Healthcare
EPS for Bayer Aktiengesellschaft (BAYRY)
EPS as of September 2026 TTM: $-0.39
According to Bayer Aktiengesellschaft's latest financial reports, its current EPS (TTM) is $-0.39. At the end of 2025 the company had an EPS of $-1.03, a decrease compared to its 2024 EPS of $-0.68.
EPS history for Bayer Aktiengesellschaft from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.39 | -62.11% |
| 2025 | $-1.03 | 52.65% |
| 2024 | $-0.68 | -18.42% |
| 2023 | $-0.83 | -172.92% |
| 2022 | $1.14 | 284.51% |
| 2021 | $0.30 | -106.13% |
| 2020 | $-4.82 | -793.33% |
| 2019 | $0.70 | 34.52% |
| 2018 | $0.52 | -79.18% |
| 2017 | $2.48 | 73.57% |
| 2016 | $1.43 | 6.28% |
| 2015 | $1.35 | 8.04% |
| 2014 | $1.25 | -6.57% |
| 2013 | $1.33 | 38.53% |
| 2012 | $0.96 | -0.82% |
| 2011 | $0.97 | 86.21% |
| 2010 | $0.52 | -15.44% |
| 2009 | $0.62 | -20.99% |
| 2008 | $0.78 | -65.33% |
| 2007 | $2.25 | 200.13% |
| 2006 | $0.75 | 37.99% |
| 2005 | $0.54 | -19.84% |
| 2004 | $0.68 | -217.04% |
| 2003 | $-0.58 | -253.34% |
| 2002 | $0.38 | 32.79% |
| 2001 | $0.28 | -50.98% |
| 2000 | $0.58 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.89 | -8,014.42% |
US
|
|
| $6.60 | -1,791.01% |
US
|
|
| $5.83 | -1,593.72% |
US
|
|
| $0.98 | -351.09% |
US
|
|
| $18.54 | -4,850.70% |
CH
|
Questions about Bayer Aktiengesellschaft's earnings per share (EPS)
What is Bayer Aktiengesellschaft's earnings per share (EPS)?
Bayer Aktiengesellschaft's earnings per share (EPS) over the last twelve months is $-0.39, as of Sep 2026.
What was Bayer Aktiengesellschaft's earnings per share (EPS) in 2025?
In 2025, Bayer Aktiengesellschaft's earnings per share (EPS) was $-1.03, compared with $-0.68 in 2024.
How has Bayer Aktiengesellschaft's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bayer Aktiengesellschaft's earnings per share (EPS) was highest in 2022 ($1.14) and lowest in 2020 ($-4.82).
How does Bayer Aktiengesellschaft's earnings per share (EPS) compare with similar companies?
Bayer Aktiengesellschaft's earnings per share (EPS) ($-0.39) is lower than that of all 5 similar companies listed above. The highest among them is Eli Lilly and Company, with $30.89.